A federal jury in Miami has found four members of the Grenon family guilty of conspiring to defraud the United States and deliver misbranded drugs. The family was charged with one count of conspiracy to defraud the United States and deliver misbranded drugs, and one count of delivering misbranded drugs. The U.S. Food and Drug Administration has warned against the use of industrial bleach as a COVID-19 treatment, and the Grenons' sentencing is scheduled for October.
Posts tagged as “FDA”
The World Health Organization (WHO) has released a statement regarding the safety of aspartame, an artificial sweetener found in Diet Coke and other sugar-free foods and drinks. The WHO's International Agency for Research on Cancer (IARC) categorized aspartame as a Group 2B carcinogen, based on limited evidence for cancer in humans. However, the U.S. Food and Drug Administration (FDA) does not agree and believes that aspartame is safe to consume in high amounts. Dr. Francesco Branca, director of the department of nutrition and food safety at WHO, has said that science is continuously expanding to assess the possible initiating or facilitating factors of cancer.
Senator Charles Schumer has called on the Food and Drug Administration to investigate PRIME, an energy drink backed by two of YouTube’s most popular stars, Logan Paul and KSI. The beverage contains high levels of caffeine, which has raised concerns among health experts and lawmakers, and the American Academy of Pediatrics has warned that it can be dangerous for children and adolescents. Schumer has urged the FDA to take action, and parents and buyers are advised to be aware of the potential health risks associated with PRIME.
This article discusses the FDA's recommendation that drugmakers update their Covid booster shots to target the predominant coronavirus strain in the US, XBB.1.5. The current vaccines still contain the original coronavirus strain, but the FDA is encouraging drugmakers to update their vaccines to ensure the best protection against the virus. The agency is also working with the CDC to ensure that the vaccines are distributed to those who need them.
The 5th Circuit Court of Appeals is hearing a case that could potentially restrict access to the abortion pill mifepristone. The anti-abortion plaintiffs argue that the FDA acted outside of its authority when it approved and expanded access to the drug. Judges, all Republican appointees, appeared to be leaning toward restricting access, which could have a major impact on women's access to safe and legal abortions in the United States. A ruling is expected in the coming weeks.
A three-judge panel of the 5th U.S. Circuit Court of Appeals in New Orleans will hear arguments Wednesday in a case that could decide the future availability of the abortion pill mifepristone. Attorneys for the FDA and the drug's manufacturer will attempt to convince the panel not to roll back accessibility to the drug, which has been used by millions of women in the U.S. and around the world. The outcome of the case could have a major impact on the availability of the drug and could affect the lives of millions of women.
The FDA has finalized a new rule that will make it easier for gay and bisexual men to donate blood. The rule will use a set of individual, risk-based questions to reduce the risk of HIV transmission, meaning that most gay and bisexual men in monogamous relationships will no longer need to abstain from sex to donate. The new guidelines are the result of a rigorous scientific process and will take effect in the coming months, helping to ensure a safe and sufficient blood supply.
Two FDA advisory panels have voted unanimously to recommend that a birth control pill, called Opill, become available without a prescription, which would make it the first birth control pill available for over-the-counter sales in the United States. The FDA is not required to follow the recommendation, but the vote is expected to weigh heavily on its final decision, expected in late summer. Advocates argue that over-the-counter access to birth control would make it more accessible and reduce the need for doctor visits.